(2R,3R,4R)-2,3,4,5-Tetrahydroxypentanal
Common Name: |
(2R,3R,4R)-2,3,4,5-Tetrahydroxypentanal |
IUPAC Name: |
(2R,3R,4R)-2,3,4,5-tetrahydroxypentanal |
Molecular Formula: |
C5H10O5 |
SMILES: |
C([C@H]([C@H]([C@H](C=O)O)O)O)O |
Inchi: |
1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h1,3-5,7-10H,2H2/t3-,4+,5-/m0/s1 |
Inchi Key: |
PYMYPHUHKUWMLA-LMVFSUKVSA-N |
Cas No: |
50-69-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
1 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
321.45 |
Mass (g/mol) |
150.053 |
Molar Refractivity |
91.10 |
Net Charge |
|
HBD |
2 |
HBA |
3 |
Rt Bonds |
15 |
Rings |
|
TPSA |
57.53 |
Hetero Atoms |
|
Heavy Atoms |
22 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
98.5 |
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
0.000000000197 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.83 |
LogP |
-2.3 |
iLOGP |
-5.32 |
XLOGP3 |
6.13 |
WLOGP |
5.08 |
MLOGP |
3.69 |
ESOL Log S |
-4.70 |
ESOL Solubility (mg/ml) |
0.006 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-7.12 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Poorly soluble |
Silicos-IT LogSw |
-4.46 |
Silicos-IT Solubility (mg/ml) |
0.01 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
1 |
Log Kp (cm/s) |
-3.91 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.054 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
0.204 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |